Page last updated: 2024-12-05

2-butene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

2-butene: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID62695
CHEBI ID48363
CHEBI ID48365
MeSH IDM0076846

Synonyms (60)

Synonym
017ngl487f ,
einecs 210-855-3
unii-017ngl487f
hsdb 5723
2-butene-trans
(e)-2-butene
2-butene, (e)-
2-butene, (2e)-
107-01-7
dimethylethylene
ccris 8971
einecs 203-452-9
brn 1718755
hsdb 180
butene, 2-
2-butene
624-64-6
trans-2-butene
trans-2-butene, >=99%
68956-54-7
(e)-but-2-ene
beta-butene
ch3ch=chch3
pseudobutylene
(2e)-2-butene
2-buten
2-trans-butene
beta-butylene
CHEBI:48363
trans-but-2-en
beta-trans-butylene
but-2-ene
CHEBI:48365
trans-but-2-ene
trans-1,2-dimethylethylene
(2e)-but-2-ene
butene-2
butylene-2
trans-butene
(e)-2-c4h8
low-boiling butene-2
B0691
einecs 273-307-2
ec 203-452-9
s1sk37516r ,
unii-s1sk37516r
3-01-00-00732 (beilstein handbook reference)
2-butene (e)-form [mi]
2-butene, trans-
.beta.-butylene, e-
e-2-butene
2-butene (e)-form
trans-2-butene [hsdb]
e-.beta.-butylene
AKOS025295555
DTXSID7027255
e-but-2-ene
2-butene,(2e)-
2-butenes, cis & trans
Q27121170
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
but-2-ene
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.06)18.7374
1990's1 (3.03)18.2507
2000's9 (27.27)29.6817
2010's12 (36.36)24.3611
2020's9 (27.27)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (2.94%)4.05%
Observational0 (0.00%)0.25%
Other33 (97.06%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]